Drug Discovery & Development

The FDA plans its third rare disease policy change in just over a year

The FDA’s new Rare Disease Framework Initiative aims to make rare disease drug reviews more consistent. A public meeting is ...
Drug Discovery & Development

AAPS names Patrick Sinko chief science officer

Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug ...
drugdiscoverytrends

Drug Discovery and Development

The FDA has finalized new guidelines for meetings between the FDA and sponsors or applicants relating to the development and review of drugs or biological products under the Prescription Drug User Fee ...
drugdiscoverytrends

Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure

After more than a year of threats and six months after President Donald Trump signed a national-security proclamation, U.S. tariffs on imported patented medicines and their ingredients expanded Sept.
drugdiscoverytrends

Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers

Google parent Alphabet and Meta reported a combined $118.5 billion in R&D expense for 2025, close to the $123.7 billion spent by the 10 largest drugmakers by revenue, a figure that includes J&J’s ...
drugdiscoverytrends

‘A plate of spaghetti’: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding

Few software releases have shaken drug discovery like AlphaFold. Its creators shared a Nobel Prize, and its public database put predicted structures for more than 200 million proteins open to ...
drugdiscoverytrends

AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists

AAPS PharmSci 360 delivers research spanning the pharmaceutical product lifecycle. Thousands of scientists and leaders, representing large and small pharma from across the globe converge at this ...
drugdiscoverytrends

Digital pathology’s next act: Mining old tissue to spare future animal studies

The field of digital pathology went from a specialist interest to a practical necessity during the pandemic, when many pathologists couldn’t get to the microscope. Digitizing slides let them keep ...
drugdiscoverytrends

Alex Federation

Few software releases have shaken drug discovery like AlphaFold. Its creators shared a Nobel Prize, and its public database put predicted structures for more than 200 million proteins open to ...
drugdiscoverytrends

small-molecule drug design

Few software releases have shaken drug discovery like AlphaFold. Its creators shared a Nobel Prize, and its public database put predicted structures for more than 200 million proteins open to ...
drugdiscoverytrends

protein targets

Few software releases have shaken drug discovery like AlphaFold. Its creators shared a Nobel Prize, and its public database put predicted structures for more than 200 million proteins open to ...